150 related articles for article (PubMed ID: 11758168)
21. Evaluation of phenotypic screening methods for detecting plasmid-mediated AmpC beta-lactamases-producing isolates of Escherichia coli and Klebsiella pneumoniae.
Lee K; Hong SG; Park YJ; Lee HS; Song W; Jeong J; Yong D; Chong Y
Diagn Microbiol Infect Dis; 2005 Dec; 53(4):319-23. PubMed ID: 16269222
[TBL] [Abstract][Full Text] [Related]
22. Fluorescein-labeled beta-lactamase mutant for high-throughput screening of bacterial beta-lactamases against beta-lactam antibiotics.
Chan PH; Chan KC; Liu HB; Chung WH; Leung YC; Wong KY
Anal Chem; 2005 Aug; 77(16):5268-76. PubMed ID: 16097768
[TBL] [Abstract][Full Text] [Related]
23. CTX-M and SHV-12 beta-lactamases are the most common extended-spectrum enzymes in clinical isolates of Escherichia coli and Klebsiella pneumoniae collected from 3 university hospitals within Korea.
Kim J; Lim YM; Rheem I; Lee Y; Lee JC; Seol SY; Lee YC; Cho DT
FEMS Microbiol Lett; 2005 Apr; 245(1):93-8. PubMed ID: 15796985
[TBL] [Abstract][Full Text] [Related]
24. [Investigation of the frequency of extended spectrum beta-lactamases and antibiotic resistance in clinical isolates of Escherichia coli and Klebsiella sp].
Ekşi F; Ozer G; Balci I
Mikrobiyol Bul; 2007 Jul; 41(3):447-52. PubMed ID: 17933257
[TBL] [Abstract][Full Text] [Related]
25. Prevalence of extended-spectrum beta-lactamase-producing Escherichia coli in a tertiary care hospital in Tehran, Iran.
Mehrgan H; Rahbar M
Int J Antimicrob Agents; 2008 Feb; 31(2):147-51. PubMed ID: 18060745
[TBL] [Abstract][Full Text] [Related]
26. Cefotaxime and ceftazidime-resistant Escherichia coli isolate producing TEM-15 beta-lactamase from a Tunisian hospital.
Chouchani C; Ben-Achour N; M'charek A; Belhadj O
C R Biol; 2007 Aug; 330(8):565-70. PubMed ID: 17637436
[TBL] [Abstract][Full Text] [Related]
27. AmpC beta-lactamase-mediated cefpodoxime-resistant Escherichia coli isolated from faecal samples of healthy volunteers.
Kaneko K; Sato Y; Tokunaga SK; Tamaki SK; Okamoto R; Inoue M
J Antimicrob Chemother; 2006 Feb; 57(2):369-71. PubMed ID: 16338950
[No Abstract] [Full Text] [Related]
28. Contribution of extended-spectrum AmpC (ESAC) beta-lactamases to carbapenem resistance in Escherichia coli.
Mammeri H; Nordmann P; Berkani A; Eb F
FEMS Microbiol Lett; 2008 May; 282(2):238-40. PubMed ID: 18371063
[TBL] [Abstract][Full Text] [Related]
29. Efficacy of amoxycillin-clavulanate in an experimental model of murine pneumonia caused by AmpC-non-hyperproducing clinical isolates of Escherichia coli resistant to cefoxitin.
Docobo-Pérez F; Fernández-Cuenca F; Pachón-Ibáñez ME; Pascual A; Pichardo C; Martínez-Martínez L; Pachón J
Clin Microbiol Infect; 2008 Jun; 14(6):582-7. PubMed ID: 18294246
[TBL] [Abstract][Full Text] [Related]
30. In vitro activity of temocillin against extended spectrum beta-lactamase-producing Escherichia coli.
Rodriguez-Villalobos H; Malaviolle V; Frankard J; de Mendonça R; Nonhoff C; Struelens MJ
J Antimicrob Chemother; 2006 Apr; 57(4):771-4. PubMed ID: 16501056
[TBL] [Abstract][Full Text] [Related]
31. SCO-1, a novel plasmid-mediated class A beta-lactamase with carbenicillinase characteristics from Escherichia coli.
Papagiannitsis CC; Loli A; Tzouvelekis LS; Tzelepi E; Arlet G; Miriagou V
Antimicrob Agents Chemother; 2007 Jun; 51(6):2185-8. PubMed ID: 17353248
[TBL] [Abstract][Full Text] [Related]
32. Effectiveness of antibiotics on the autochthonous Escherichia coli of mice in the intestinal biofilm versus its planktonic phase.
Kétyi I
Acta Microbiol Immunol Hung; 1994; 41(2):189-95. PubMed ID: 7804722
[TBL] [Abstract][Full Text] [Related]
33. SHV-5 extended-spectrum beta-lactamases in clinical isolates of Escherichia coli in Malaysia.
Subramaniam G; Palasubramaniam S; Navaratnam P
Indian J Med Microbiol; 2006 Jul; 24(3):205-7. PubMed ID: 16912441
[TBL] [Abstract][Full Text] [Related]
34. Statistical study of intrinsic resistance in Escherichia coli.
Roy C; Segura C; Teruel D; Teixell M; Reig R; Hermida M
Chemioterapia; 1987 Jun; 6(2 Suppl):197-8. PubMed ID: 3334557
[No Abstract] [Full Text] [Related]
35. Extended-spectrum beta-lactamase (ESBL) CTX-M-15-producing Escherichia coli and Klebsiella pneumoniae in Sofia, Bulgaria.
Markovska R; Schneider I; Keuleyan E; Bauernfeind A
Clin Microbiol Infect; 2004 Aug; 10(8):752-5. PubMed ID: 15301679
[TBL] [Abstract][Full Text] [Related]
36. Mutagenic effect of acridine orange on the expression of penicillin G acylase and beta-lactamase in Escherichia coli.
Arshad R; Farooq S; Iqbal N; Ali SS
Lett Appl Microbiol; 2006 Feb; 42(2):94-101. PubMed ID: 16441371
[TBL] [Abstract][Full Text] [Related]
37. beta-Lactamases and beta-lactam resistance in Escherichia coli.
Jacoby GA; Sutton L
Antimicrob Agents Chemother; 1985 Nov; 28(5):703-5. PubMed ID: 3911882
[TBL] [Abstract][Full Text] [Related]
38. Prevalence and antimicrobial resistance patterns of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae isolated from blood cultures in an Istanbul University Hospital.
Koksal F; Ak K; Kucukbasmaci O; Samasti M
Chemotherapy; 2009; 55(4):293-7. PubMed ID: 19521075
[TBL] [Abstract][Full Text] [Related]
39. Mutators among CTX-M beta-lactamase-producing Escherichia coli and risk for the emergence of fosfomycin resistance.
Ellington MJ; Livermore DM; Pitt TL; Hall LM; Woodford N
J Antimicrob Chemother; 2006 Oct; 58(4):848-52. PubMed ID: 16891630
[TBL] [Abstract][Full Text] [Related]
40. An electrochemiluminescent method for the detection of beta-lactamases in microorganisms.
Priano G; Ruzal SM; Battaglini F
Anal Biochem; 2001 Mar; 290(2):379-82. PubMed ID: 11237344
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
